After the strong growth in membership of the last few years, a new member is joining Interpharma on 1 January 2017 in the shape of Shire. This will bring to 24 the number of Interpharma member companies that make a major contribution to medical progress in general and to improvements in the quality of life for the individual patient with their various treatments and therapies. The market share of Interpharma member companies in the Swiss pharmaceuticals market for patent-protected, reimbursable medicines stands at 92%.